Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brian Concannon currently holds 5,503 shares of HAEMONETICS CORP (HAE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brian Concannon has been a net seller of HAE stock. They have purchased $82.3K and sold $18.6M worth of shares.
Brian Concannon's most recent insider trade was on Jun 3, 2024, when they sold 5,503 shares at $0.00 per share.
Brian Concannon serves as Executive at HAEMONETICS CORP (HAE). They have executed 239 insider transactions totaling $18.7M over their tenure at the company.
Brian Concannon holds the position of Executive at HAEMONETICS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Brian Concannon has shown a selling trading pattern, with $82.3K in total purchases and $18.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Brian Concannon was on Feb 2, 2022, when they sold $575.2K worth of CNMD shares. This transaction involved 4,200 shares at $136.96 per share.
Brian Concannon currently owns 5,503 shares of HAEMONETICS CORP (HAE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brian Concannon's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brian Concannon has 239 Form 4 filings on record as an insider at HAEMONETICS CORP.
Set alerts for Brian Concannon and 40,000+ other insiders.